AxoGen Profile

26.5
USD 0.3  1.15%
24.3Last Month High 26.7 
26.1Trading Day  High 27.1 

Sale by Jamie Grooms of 31805 shares of AxoGen

AxoGen Inc insider trading alert for sale of common stock by Jamie Grooms, the corporate stakeholder, on December 8, 2017. This event was filed by Axogen Inc with SEC on 2017-12-08. Statement of changes in beneficial ownership - SEC Form 4. Jamie Grooms is currently serves as co-founder, chairman, member of audit committee and member of governance and nominating committee of AxoGen Inc [view details]   

AxoGen Summary

AxoGen Inc (AXGN) is traded on Nasdaq Capital Markets in USA. It is located in FLORIDA, U.S.A and employs 113 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 893.26 M. AxoGen Inc has 34.09 M outstanding shares of which 975.73 K shares are presently shorted by private and institutional investors with about 4.01 trading days to cover. AXOGEN INC currently holds about 22.04 M in cash with (9.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.66.
Check AxoGen Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Essex Woodlands Health Ventures IncCommon Shares4.9 M94.1 M
Opaleye Management IncCommon Shares2 M38.1 M
View AxoGen Diagnostics

Selected AxoGen Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

AxoGen Against Markets

Risk Adjusted
Performance Score (0 to 100)
7 
Chance of
< 1% 
AxoGen, Inc. operates as a medical technology company. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameAxoGen Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationFLORIDA, U.S.A
Business AddressAxoGen, Inc.Alachua, FL
ExchangeNasdaq Capital Markets
CIK Number00805928.0
CUSIP05463X106
IndustryMedical Equipment
BenchmarkDOW
Websitewww.axogeninc.com
Contact Number386 462 6800
CurrencyUSD - US Dollar

Recommendations

AxoGen Analyst Recommendations
Target PriceAdvice# of Analysts
8.92Buy3Odds
AxoGen Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
AxoGen Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

AxoGen Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.1February 22, 2017
AxoGen Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate